Stock Agreements in the Pharmaceuticals Industry

1,775 Contracts & Agreements

Browse by Company

Acasti Pharma Inc. (4 contracts)
Accelerated Pharma, Inc. (1)
ACELRX PHARMACEUTICALS INC (9)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (4)
Acreage Holdings, Inc. (6)
ACURA PHARMACEUTICALS, INC (8)
Adamis Pharmaceuticals Corp (17)
ADIAL PHARMACEUTICALS, INC. (6)
Aegerion Pharmaceuticals, Inc. (18)
AEOLUS PHARMACEUTICALS, INC. (7)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (18)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (7)
Akers Biosciences, Inc. (6)
AKESIS PHARMACEUTICALS, INC. (10)
Akorn (15)
ALDER BIOPHARMACEUTICALS INC (7)
Alexza Pharmaceuticals Inc. (11)
ALGORX PHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (4)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (15)
Altus Pharmaceuticals Inc. (9)
Amag Pharmaceuticals (36)
Amphastar Pharma (4)
Ampio Pharmaceuticals, Inc. (8)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (3)
ANADYS PHARMACEUTICALS INC (2)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (3)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (6)
APP Pharmaceuticals, Inc. (1)
Applied BioSciences Corp. (3)
APRICUS BIOSCIENCES, INC. (9)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (5)
Aralez Pharmaceuticals Inc. (5)
ARIAD PHARMACEUTICALS INC (13)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (9)
ARVINAS, INC. (4)
Assertio Therapeutics, Inc (13)
Astex Pharmaceuticals, Inc (2)
ATAI Life Sciences B.V. (8)
Atea Pharmaceuticals, Inc. (5)
Athira Pharma, Inc. (3)
Auspex Pharmaceuticals, Inc. (5)
AUXILIUM PHARMACEUTICALS INC (14)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (1)
AVANIR PHARMACEUTICALS, INC. (5)
AVENUE THERAPEUTICS, INC. (2)
AXIM BIOTECHNOLOGIES, INC. (5)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (5)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (3)
Bausch Health Companies Inc. (8)
BENTLEY PHARMACEUTICALS INC (1)
Bespoke Extracts, Inc. (2)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (10)
Biofrontera Inc. (2)
BioNumerik Pharmaceuticals, Inc. (8)
BioPharmX Corp (9)
Blue Water Acquisition Corp. (5)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (9)
Braeburn Pharmaceuticals, Inc. (1)
Bright Green Corp (1)
Bristol-Myers Squibb (8)
Canbiola, Inc. (9)
Cancer Prevention Pharmaceuticals, Inc. (6)
CANNAPHARMARX, INC. (1)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (6)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (6)
CASSAVA SCIENCES INC (4)
Catalent Inc (15)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (1)
Cerecor Inc. (6)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (3)
CHINA PHARMA HOLDINGS, INC. (1)
China Yongxin Pharmaceuticals Inc. (1)
CinCor Pharma, Inc. (3)
Cingulate Inc. (5)
Citius Pharmaceuticals, Inc. (4)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (3)
CLS Holdings USA, Inc. (2)
CNS Pharmaceuticals, Inc. (1)
Cocrystal Pharma, Inc. (6)
COGNITION THERAPEUTICS INC (5)
COLLAGENEX PHARMACEUTICALS INC (2)
COLLEGIUM PHARMACEUTICAL, INC (8)
CoLucid Pharmaceuticals, Inc. (3)
Columbia Care Inc. (3)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (2)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (3)
CPEX Pharmaceuticals, Inc. (4)
Cronos Group Inc. (6)
CUBIST PHARMACEUTICALS INC (7)
CUMBERLAND PHARMACEUTICALS INC (5)
Cure Pharmaceutical Holding Corp. (2)
CymaBay Therapeutics, Inc. (3)
Cyteir Therapeutics, Inc. (2)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (11)
Edgewise Therapeutics, Inc. (4)
Egalet Corp (8)
Elanco Animal Health Inc (11)
Eleison Pharmaceuticals Inc (1)
ELITE PHARMACEUTICALS INC (6)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (12)
ENCYSIVE PHARMACEUTICALS INC (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (4)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (3)
Evolus, Inc. (4)
Exactus, Inc. (11)
EYEGATE PHARMACEUTICALS INC (4)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (8)
EYETECH PHARMACEUTICALS INC (6)
FRONTIER OILFIELD SERVICES INC (3)
Fulcrum Therapeutics, Inc. (3)
GENAISSANCE PHARMACEUTICALS INC (5)
GFR PHARMACEUTICALS INC (1)
GRAYBUG VISION, INC. (5)
GREEN HYGIENICS HOLDINGS INC. (2)
GridIron BioNutrients, Inc. (2)
Harmony Biosciences Holdings, Inc. (2)
HARROW HEALTH, INC. (10)
Haymaker Acquisition Corp. III (4)
HERATSI PHARMACEUTICALS (1)
Horizon Pharma plc (6)
Hoth Therapeutics, Inc. (3)
IDENIX PHARMACEUTICALS INC (5)
Ikena Oncology, Inc. (2)
IMARA Inc. (4)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (10)
INSPIRE PHARMACEUTICALS INC (10)
IntelGenx Technologies Corp. (4)
Intersect ENT, Inc. (4)
Intra-Cellular Therapies, Inc. (2)
ISTA PHARMACEUTICALS INC (6)
Jaguar Health, Inc. (18)
JAVELIN PHARMACEUTICALS, INC (3)
Jazz Pharmaceuticals plc (36)
Johnson & Johnson (5)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (7)
Kala Pharmaceuticals, Inc. (8)
Kaleido Biosciences, Inc. (2)
Kannalife Inc (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (2)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (4)
Lev Pharmaceuticals Inc (2)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (16)
Lilly (Eli) & Co. (33)
LIPELLA PHARMACEUTICALS INC (1)
Lipocine Inc. (2)
Liquidia Corp (5)
Liquidia Technologies Inc (2)
Longboard Pharmaceuticals, Inc. (3)
Lyra Therapeutics, Inc. (4)
Mallinckrodt (4)
MAP Pharmaceuticals, Inc. (6)
Marijuana Co of America, Inc. (2)
MARINUS PHARMACEUTICALS INC (3)
MAXIM PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (9)
MEMORY PHARMACEUTICALS CORP (4)
Menlo Therapeutics Inc. (3)
Merck (2)
MICROCHANNEL TECHNOLOGIES CORP (7)
MiddleBrook Pharmaceuticals, Inc. (4)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (2)
MJ Holdings, Inc. (4)
Molecular Insight Pharmaceuticals, Inc. (6)
MYnd Analytics, Inc. (12)
MyoKardia Inc (3)
Mystic Holdings Inc. (1)
Nabriva Therapeutics plc (1)
NAREK PHARMACEUTICALS (1)
NEKTAR THERAPEUTICS (10)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (12)
NewBridge Global Ventures, Inc. (8)
NGM BIOPHARMACEUTICALS INC (4)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (8)
NOVEN PHARMACEUTICALS INC (7)
NPS PHARMACEUTICALS INC (13)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (6)
Odonate Therapeutics, Inc. (6)
OMEROS CORP (6)
Omthera Pharmaceuticals, Inc. (3)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (5)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (3)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (8)
Organon & Co. (1)
OSI PHARMACEUTICALS INC (9)
OTONOMY, INC. (1)
Pacira Pharmaceuticals, Inc. (6)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (7)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (1)
PENWEST PHARMACEUTICALS CO (3)
Perrigo (4)
Petros Pharmaceuticals, Inc. (3)
Pfizer (7)
PHARMOS CORP (1)
Phathom Pharmaceuticals, Inc. (3)
Phibro Animal Health Corporation (1)
PLAYERS NETWORK (10)
PLIANT THERAPEUTICS, INC. (2)
PLx Pharma Inc. (3)
PONIARD PHARMACEUTICALS, INC. (4)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (9)
Prestige Brands Holdings Inc (3)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (5)
PROTEO INC (7)
PROVECTUS BIOPHARMACEUTICALS, INC. (2)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (3)
QUANTA INC (2)
QUARK PHARMACEUTICALS INC (18)
QUATRX PHARMACEUTICALS CO (3)
QUESTCOR PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (4)
RADIENT PHARMACEUTICALS Corp (8)
Rain Therapeutics Inc. (5)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (9)
Recro Pharma, Inc. (15)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (7)
RespireRx Pharmaceuticals Inc. (22)
resTORbio, Inc. (7)
Revance Therapeutics, Inc. (9)
Rib-X Pharmaceuticals, Inc. (4)
ROCK CREEK PHARMACEUTICALS, INC. (9)
Roivant Sciences Ltd. (1)
SALIX PHARMACEUTICALS LTD (7)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (9)
SCICLONE PHARMACEUTICALS INC (10)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (2)
SCYNEXIS INC (16)
SenesTech, Inc. (8)
Sienna Biopharmaceuticals, Inc. (1)
Sirtris Pharmaceuticals, Inc. (5)
Sonoma Pharmaceuticals, Inc. (12)
Strongbridge Biopharma plc (6)
Sucampo Pharmaceuticals, Inc. (3)
SUNWIN STEVIA INTERNATIONAL, INC. (5)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (4)
Synovics Pharmaceuticals (2)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (3)
TAURIGA SCIENCES, INC. (4)
Tenzing Acquisition Corp. (1)
Terns Pharmaceuticals, Inc. (4)
Terra Tech Corp. (24)
TETRAPHASE PHARMACEUTICALS INC (4)
TFF Pharmaceuticals, Inc. (2)
The Medicines Company (2)
TherapeuticsMD, Inc. (4)
Theseus Pharmaceuticals, Inc. (3)
TITAN PHARMACEUTICALS INC (11)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Tricida, Inc. (7)
Trulieve Cannabis Corp. (5)
Urigen Pharmaceuticals, Inc. (1)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (16)
Ventyx Biosciences, Inc. (4)
Verano Holdings Corp. (1)
VERBENA PHARMACEUTICALS INC (1)
Verrica Pharmaceuticals Inc. (3)
VIA Pharmaceuticals, Inc. (9)
Viamet Pharmaceuticals Holdings LLC (1)
VICURON PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (11)
Virpax Pharmaceuticals, Inc. (4)
Vitae Pharmaceuticals, Inc (6)
Vitality Biopharma, Inc. (4)
VIVUS INC (6)
WEED, INC. (2)
XANODYNE PHARMACEUTICALS INC (3)
XERIS PHARMACEUTICALS INC (2)
Zoetis (9)
ZOGENIX, INC. (4)
Zomedica Pharmaceuticals Corp. (3)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (TITAN PHARMACEUTICALS INC, Filed With SEC on September 19, 2023)
CNS Pharmaceuticals, Inc. 2020 Stock Plan (as amended September 14, 2023) (CNS Pharmaceuticals, Inc., Filed With SEC on September 19, 2023)
Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (TITAN PHARMACEUTICALS INC, Filed With SEC on September 18, 2023)
Stock Purchase Agreement dated September 4, 2023 by and between Zomedica Inc., Sellers and SMP VG Holdco Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on September 6, 2023)
Second Amendment to Stock Purchase Agreement dated as of August 21, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (ORAMED PHARMACEUTICALS INC., Filed With SEC on August 22, 2023)
Form of Stock Option Agreement for Employees under the Acasti Pharma Inc. Stock Option Plan (Acasti Pharma Inc., Filed With SEC on August 11, 2023)
Form of Stock Option Agreement for Non-Employee Directors under the Acasti Pharma Stock Option Plan (Acasti Pharma Inc., Filed With SEC on August 11, 2023)
First Amendment to Stock Purchase Agreement dated August 9, 2023, by and between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (ORAMED PHARMACEUTICALS INC., Filed With SEC on August 10, 2023)
Stock Purchase Agreement dated as of August 7, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (ORAMED PHARMACEUTICALS INC., Filed With SEC on August 9, 2023)
Form of Restricted Stock Unit Award Agreement for Directors (Immediate or Deferred Settlement) (Trulieve Cannabis Corp., Filed With SEC on August 9, 2023)
Form of Restricted Stock Unit Award Agreement for Executive Officers (Trulieve Cannabis Corp., Filed With SEC on August 9, 2023)
Form of Nonqualified Stock Option Agreement for Directors (Trulieve Cannabis Corp., Filed With SEC on August 9, 2023)
Form of Nonqualified Stock Option Agreement for Executive Officers (Trulieve Cannabis Corp., Filed With SEC on August 9, 2023)
Form of Equity Award Agreement for Stock Option (Verano Holdings Corp., Filed With SEC on August 8, 2023)
Form of Non-Employee Restricted Stock Unit Award Agreement (Atea Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
Form of Non-Employee Stock Option Award Agreement (Atea Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
Form of Inducement Restricted Stock Unit Agreement (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Form of Certificate of Designation under Asset Purchase Agreement for Series E Convertible Preferred Stock (Exactus, Inc., Filed With SEC on July 10, 2023)
Stock and Asset Purchase Agreement by and among Buyer, Novartis and, for the limited purposes set forth therein, Bausch + Lomb, dated as of June 30, 2023 (Bausch Health Companies Inc., Filed With SEC on July 7, 2023)
Form of Avenue Therapeutics, Inc. Stock Option Agreement (AVENUE THERAPEUTICS, INC., Filed With SEC on July 5, 2023)
Amended & Restated Roivant Sciences Ltd. Employee Stock Purchase Plan (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Journey Medical Corporation 2023 Employee Stock Purchase Plan (Journey Medical Corp, Filed With SEC on June 23, 2023)
DURECT Corporation 2000 Employee Stock Purchase Plan, as amended (DURECT CORP, Filed With SEC on June 22, 2023)
Palisade 2021 Employee Stock Purchase Plan, as amended (Neuralstem, Inc., Filed With SEC on June 9, 2023)
Axsome Therapeutics, Inc. 2023 Employee Stock Purchase Plan (Axsome Therapeutics, Inc., Filed With SEC on June 8, 2023)
Form of Restricted Stock Agreement (Exactus, Inc., Filed With SEC on June 2, 2023)
DMK 2016 Stock Plan (Adamis Pharmaceuticals Corp, Filed With SEC on May 26, 2023)
CalciMedica, Inc. 2023 Employee Stock Purchase Plan (GRAYBUG VISION, INC., Filed With SEC on May 12, 2023)
Form of Restricted Stock Unit Agreement (Edgewise Therapeutics, Inc., Filed With SEC on May 11, 2023)
Evoke Pharma, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (Evoke Pharma Inc, Filed With SEC on May 11, 2023)
Forms of Service-based Restricted Stock Unit Award Agreement (Perrigo, Filed With SEC on May 9, 2023)
Form of Cash Restricted Stock Unit Award Agreement, effective as of February 8, 2023 (Zoetis, Filed With SEC on May 4, 2023)
Form of Non-Employee Director Restricted Stock Unit Award Agreement, effective as of February 8, 2023 (Zoetis, Filed With SEC on May 4, 2023)
Stock Purchase Agreement between Big Bhang Events, LLC, NMG MI 1, Inc. and DEP Nevada, Inc., dated April 14, 2023 (BODY & MIND INC., Filed With SEC on April 19, 2023)
Amendment to Walleye Common Stock Purchase Agreement (Canbiola, Inc., Filed With SEC on April 17, 2023)
Form of Contingent Value Rights Agreement to be entered into between Shin Nippon Biomedical Laboratories, Ltd. and American Stock Transfer & Trust Company, LLC (Satsuma Pharmaceuticals, Inc., Filed With SEC on April 17, 2023)
Form of Subscription Agreement for Shares of Common Stock (Scopus BioPharma Inc., Filed With SEC on April 14, 2023)
Form of Voting Agreement by and among the Company, holders of shares of Series V Preferred Stock, and Sabas Carrillo, including Exhibit 10.54.1 (Terra Tech Corp., Filed With SEC on April 10, 2023)
Description of Capital Stock of Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 29, 2023)
Form of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan (ProPhase Labs, Inc., Filed With SEC on March 29, 2023)